CIK 0001104506
- Large accelerated filer
INSMED Inc
Sign in to watch- Ticker
- INSM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- VA
- Entity type
- Operating
- EIN
- 541972729
- Phone
- +1 908-977-9900
- Business address
- 700 US HIGHWAY 202/206, BRIDGEWATER, NJ, 08807
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,100,000
- in 1 filing
Net −$3,100,000. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-12-19 | Lewis William Chair and CEO | Exercise or conversion · Stock Option (right to buy) 10b5-1 | −6,830 | 232,290 | ||
| 2024-12-12 | Lewis William Chair and CEO | Exercise or conversion 10b5-1 | +18,750 | $22.76 | $427K | 403,710 |
| 2024-12-12 | Lewis William Chair and CEO | Sale 10b5-1 | −11,504 | $72.58 | $835K | 392,206 |
| 2024-12-12 | Lewis William Chair and CEO | Sale 10b5-1 | −6,847 | $73.56 | $504K | 385,359 |
| 2024-12-12 | Lewis William Chair and CEO | Sale 10b5-1 | −399 | $74.23 | $30K | 384,960 |
| 2024-12-12 | Lewis William Chair and CEO | Exercise or conversion 10b5-1 | +6,830 | $10.85 | $74K | 240,754 |
| 2024-12-12 | Lewis William Chair and CEO | Sale 10b5-1 | −4,087 | $72.57 | $297K | 236,667 |
| 2024-12-12 | Lewis William Chair and CEO | Sale 10b5-1 | −2,562 | $73.55 | $188K | 234,105 |
| 2024-12-12 | Lewis William Chair and CEO | Sale 10b5-1 | −181 | $74.22 | $13K | 233,924 |
| 2024-12-12 | Lewis William Chair and CEO | Exercise or conversion · Stock Option (right to buy) 10b5-1 | −18,750 | 131,250 | ||
| 2024-12-12 | Lewis William Chair and CEO | Exercise or conversion · Stock Option (right to buy) 10b5-1 | −6,830 | 239,120 | ||
| 2024-09-16 | Flammer Martina M.D. Chief Medical Officer | Exercise or conversion 10b5-1 | +13,436 | $34.03 | $457K | 119,570 |
| 2024-09-16 | Flammer Martina M.D. Chief Medical Officer | Sale 10b5-1 | −13,436 | $74.92 | $1.0M | 106,134 |
| 2024-09-16 | Flammer Martina M.D. Chief Medical Officer | Exercise or conversion · Stock Option (right to buy) 10b5-1 | −13,436 | 13,680 | ||
| 2024-09-13 | Smith Michael Alexander Chief Legal Officer | Exercise or conversion 10b5-1 | +7,000 | $22.76 | $159K | 95,727 |
| 2024-09-13 | Smith Michael Alexander Chief Legal Officer | Sale 10b5-1 | −18,871 | $74.16 | $1.4M | 76,856 |
| 2024-09-13 | Smith Michael Alexander Chief Legal Officer | Sale 10b5-1 | −9,000 | $74.75 | $673K | 67,856 |
| 2024-09-13 | Smith Michael Alexander Chief Legal Officer | Exercise or conversion · Stock Option (right to buy) 10b5-1 | −7,000 | 0 | ||
| 2024-09-13 | Flammer Martina M.D. Chief Medical Officer | Exercise or conversion 10b5-1 | +26,969 | $34.03 | $918K | 133,103 |
| 2024-09-13 | Flammer Martina M.D. Chief Medical Officer | Sale 10b5-1 | −26,969 | $74.90 | $2.0M | 106,134 |
Page 35 of 42 · 826 trades